Yoğun Bakımda COVID-19 ve ECMO
Özet
Ekstrakorporeal membran oksijenasyonu (ECMO), geleneksel tedavilerin yetersiz kaldığı şiddetli COVID-19 kaynaklı akut solunum sıkıntısı sendromu (ARDS) ve refrakter solunum veya kalp yetmezliği olgularında hayat kurtarıcı bir destek ünitesi olarak öne çıkmaktadır. Dünya Sağlık Örgütü ve ELSO gibi uluslararası kuruluşlar, özellikle akciğer koruyucu mekanik ventilasyonun ve pron pozisyonunun yetersiz kaldığı durumlarda uzman merkezlerde ECMO'nun değerlendirilmesini önermektedir. Bu süreçte hasta seçimi, kaynakların kısıtlı olması nedeniyle büyük önem taşır; zira ileri yaş, morbid obezite ve uzun süreli ventilasyon gibi durumlar göreceli kontrendikasyon teşkil eder. Tedavide venoarteryel (VA) ve venövenöz (VV) olmak üzere iki temel kanülasyon stratejisi uygulanmakta, solunum desteği için sıklıkla tercih edilen VV-ECMO'da oksijenlenmiş kanın sistemik dolaşıma girmeden geri çekilmesi anlamına gelen "resirkülasyon" verimliliği azaltabilmektedir. Güvenli bir ECMO uygulamasının ardından akciğer istirahatini hedefleyen koruyucu mekanik ventilasyon stratejileri sürdürülmeli ve koagülopati risklerine karşı heparin temelli hassas bir antikoagülasyon yönetimi gerçekleştirilmelidir. Hastanın durumunun stabil seyretmesiyle birlikte adım adım gaz akımı düşürülerek weaning (ayırma) protokolü uygulanır ve tedavi, olası enfeksiyon ile kanama gibi komplikasyonlar yakından izlenerek sonlandırılır.
Extracorporeal membrane oxygenation (ECMO) stands out as a life-saving support unit in severe COVID-19-induced acute respiratory distress syndrome (ARDS) and refractory respiratory or cardiac failure cases where conventional therapies fail. International organizations such as the World Health Organization and ELSO recommend evaluating ECMO in specialized centers, particularly when lung-protective mechanical ventilation and prone positioning remain insufficient. Patient selection is critical during this process due to limited resources, as advanced age, morbid obesity, and prolonged ventilation represent relative contraindications. Two primary cannulation strategies, venoarterial (VA) and venovenous (VV), are utilized in treatment; in VV-ECMO, which is frequently preferred for respiratory support, "recirculation"—the withdrawal of oxygenated blood before entering systemic circulation—can reduce efficiency. Following safe ECMO initiation, protective mechanical ventilation strategies targeting lung rest should be maintained, and precise anticoagulation management based on heparin must be executed against coagulopathy risks. Once the patient's condition stabilizes, a weaning protocol is performed by step-by-step reductions in gas flow, and the treatment is concluded under close monitoring for potential complications such as infection and bleeding.
Referanslar
Maclaren G, Fisher D, Brodie D. Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation. JAMA. 2020;323(13):1245–1246.
Barbaro RP, MacLaren G, Boonstra PS, et al. Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396(10257):1071–1078.
Brodie D, Slutsky AS, Combes A. Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A Review. JAMA. 2019;322(6):557–568.
Goligher EC, Tomlinson G, Hajage D, et al. Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial. JAMA. 2018;320(21):2251–2259.
Supady A, Curtis JR, Abrams D, et al. Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks. Lancet Respir Med. 2021;9(4):430–4.
Badulak J, Antonini MV, Stead CM, et al. Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO J. 2021;485–495.
Abrams D, Ferguson ND, Brochard L, et al. ECMO for ARDS: from salvage to standard of care?. Lancet Respir Med. 2019;7:108–110.
Rajagopal K, Slepian MJ, Keller SP, et al. Circulation: Heart Failure Advanced Pulmonary and Cardiac Support of COVID-19 Patients Emerging Recommendations From ASAIO-a Living Working Document. ASAIO J. 2020;13:1-12
Schamroth Pravda N, Schamroth Pravda M, Kornowski R, Orvin K. Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic. Future Cardiol. Doi: 10.2217/fca-2020-0040
Harnisch LO, Moerer O. Contraindications to the Initiation of Veno-Venous ECMO for Severe Acute Respiratory Failure in Adults: A Systematic Review and Practical Approach Based on the Current Literature. Membranes. 2021;11(8).
Hoyler MM, Flynn B, Iannacone EM, Jones MM, Ivascu NS. Clinical Management of Venoarterial Extracorporeal Membrane Oxygenation. J Cardiothorac Vasc Anesth. 2020;34(10):2776–2792.
Napp LC, Kühn C, Hoeper MM, et al. Cannulation strategies for percutaneous extracorporeal membrane oxygenation in adults. Clin Research Cardiol. 2016;105:283–296.
Jayaraman A, Cormican D, Shah P, Ramakrishna H. Cannulation strategies in adult veno-arterial and veno-venous extracorporeal membrane oxygenation: Techniques, limitations, and special considerations. Ann Card Anaesth. Medknow Publications; 2017;20:11–18.
Chacon MM, Shillcutt SK. Intraoperative Transesophageal Echocardiography–Guided Placement of Bicaval Dual-Lumen Extracorporeal Membrane Oxygenation Cannula. CASE Cardiovasc Imaging Case Reports. 2017;1(3):116.
De Silva RJ, Soto C, Spratt P. Extra corporeal membrane oxygenation as right heart support following left ventricular assist device placement: a new cannulation technique. Heart Lung Circ. 2012;21(4):218–220.
Abrams D, Bacchetta M, Brodie D. Recirculation in venovenous extracorporeal membrane oxygenation. ASAIO J. 2015;61(2):115–121.
Abrams D, Brodie D, Identification and management of recirculation in venovenous ECMO: Guideline from the Extracorporeal Life Support Organization (ELSO) ASAIO J. 2018;1-10.
Tonna JE, Abrams D, Brodie D, et al. Management of Adult Patients Supported with Venovenous Extracorporeal Membrane Oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO J. 2021;601–610.
Schmidt M, Pham T, Arcadipane A, et al. Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort. Am J Respir Crit Care Med. 2019;200(8):1002–1012.
Araos J, Alegria L, Garcia P, et al. Near-Apneic Ventilation Decreases Lung Injury and Fibroproliferation in an Acute Respiratory Distress Syndrome Model with Extracorporeal Membrane Oxygenation. Am J Respir Crit Care Med. 2019;199:603–612.
Rhoades R, Leong R, Kopenitz J, et al. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy. Thromb Res. 2021;203:1–4.
Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth. 2009;13(3):154–175.
Doymaz S. Anticoagulation during ECMO: The Past, Present and Future. J Intensive Crit Care. 2018;4(2):12. Doi: 10.21767/2471-8505.100114
Zhang Z, Gu WJ, Chen K, Ni H. Mechanical Ventilation during Extracorporeal Membrane Oxygenation in Patients with Acute Severe Respiratory Failure. Can Respir J. 2017;1-10. Doi:10.1155/2017/1783857
Han H, Yang L, Liu R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58(7):1116–1120.
Savarimuthu S, BinSaeid J, Harky A. The role of ECMO in COVID-19: Can it provide rescue therapy in those who are critically ill? . J Card Surg. 2020;35:1298–1301.
